Home › Researcher directory › Patrick Van Dreden

Patrick Van Dreden

Affiliation : Inserm · Sorbonne Université · Stago (France) · Assistance Publique – Hôpitaux de Paris · Hôpital Saint-Antoine · Centre de Recherche Saint-Antoine

• 7Publications (affiliation in France)
• 221Total publications
• 2472Citations
• 26h-index

ORCIDOpenAlex

Research profile

Patrick Van Dreden has 7 indexed publications (2012–2026). Their work appears mainly in “Clinical and Applied Thrombosis/Hemostasis”, “Blood” and “International Journal of Molecular Sciences”. Their most cited article, “Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability” (2014), has been cited 50 times. 2 of these publications date from the last three years of activity. Their work is co-authored with at least 12 researchers, including institutions in United States, Tunisia, Russia, Greece.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

• Blood Coagulation and Thrombosis Mechanisms
• Venous Thromboembolism Diagnosis and Management
• Blood properties and coagulation
• Complement system in diseases
• COVID-19 Clinical Research Studies

Publications (7)

• Biomarkers of Hypercoagulability and Thromboinflammation in Cervical Cancer-Associated Thrombosis: A Systematic Review with Translational Insights from Breast Cancer
  2026 · International Journal of Molecular Sciences
• Cardiovascular Symposium on Perspectives in Long COVID
  2025 · Clinical and Applied Thrombosis/Hemostasis · cited 2 times
• The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper
  2021 · Thrombosis and Haemostasis · cited 31 times
• The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1
  2016 · Clinical and Applied Thrombosis/Hemostasis · cited 6 times
• Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability
  2014 · BMC Cancer · cited 50 times
• Markers of Hypercoagulability in Breast Cancer: What Is Their Clinical Relevance?
  2012 · Blood
• Hypercoagulability Linked to Breast Cancer Depends On the Stage and the Duration of the Tumor Evolution
  2012 · Blood

Publication venues

• Clinical and Applied Thrombosis/Hemostasis × 2
• Blood × 2
• International Journal of Molecular Sciences × 1
• Thrombosis and Haemostasis × 1
• BMC Cancer × 1

Publications per year

• 20261
• 20251
• 20211
• 20161
• 20141
• 20122

Collaborations

Partner institutions : Hôpital Tenon · Université Pierre-et-Marie-Curie · Sechenov University · Hopital Universitaire Habib Bourguiba · Laboratoire d'hématologie

Co-authors’ countries : United States · Tunisia · Russia · Greece

Co-authors

• Grigoris Gerotziafas
• Ismaı̈l Elalamy
• Vassiliki Galea
• Mourad Chaari
• Joseph Gligorov
• Barry John Woodhams
• Eleftheria Elmina Lefkou
• Aurélie Rousseau
• Pedro Henrique Fernandes do Carmo Las Casas
• Taher Chakroun
• Mohamed Hatmi
• Vincent Maréchal

Bibliographic data from OpenAlex (open database).